United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 244,500 | 417,900 | 398,900 | 122,600 | 178,600 |
| Depreciation Amortization | 7,900 | 31,000 | 23,300 | 15,600 | 7,900 |
| Accounts receivable | 86,000 | -82,700 | -37,300 | -59,400 | 26,500 |
| Accounts payable and accrued liabilities | 22,000 | 66,200 | 37,900 | 20,800 | -1,100 |
| Other Working Capital | 124,500 | -78,400 | -68,500 | -62,300 | 71,900 |
| Other Operating Activity | -209,200 | 120,200 | 205,700 | 264,200 | -53,000 |
| Operating Cash Flow | $275,700 | $474,200 | $560,000 | $301,500 | $230,800 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,100 | -757,700 | -507,100 | -320,600 | -150,000 |
| PPE Investments | -37,600 | -78,000 | -50,200 | -36,500 | -15,600 |
| Other Investing Activity | 0 | 100 | 100 | 100 | 0 |
| Investing Cash Flow | $-58,700 | $-835,600 | $-557,200 | $-357,000 | $-165,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 250,000 | 250,000 | 250,000 | N/A |
| Common Stock Issued | 11,300 | 44,000 | 42,200 | 38,700 | 35,100 |
| Common Stock Repurchased | N/A | -250,000 | -250,000 | -250,000 | N/A |
| Other Financing Activity | -700 | -700 | -700 | -700 | -700 |
| Financing Cash Flow | $10,600 | $43,300 | $41,500 | $38,000 | $34,400 |
| Exchange Rate Effect | N/A | 200 | 200 | 400 | N/A |
| Beginning Cash Position | 705,100 | 1,023,000 | 1,023,000 | 1,023,000 | 1,023,000 |
| End Cash Position | 932,700 | 705,100 | 1,067,500 | 1,005,900 | 1,122,600 |
| Net Cash Flow | $227,600 | $-317,900 | $44,500 | $-17,100 | $99,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 275,700 | 474,200 | 560,000 | 301,500 | 230,800 |
| Capital Expenditure | -37,600 | -86,300 | -58,500 | -36,500 | -15,600 |
| Free Cash Flow | 238,100 | 387,900 | 501,500 | 265,000 | 215,200 |